Related Experiment Video
Updated: May 27, 2026
06:06
Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones
Published on: February 5, 2018
[Designer drugs in Finland]
Ulrich Tacke1, Bjørnar den Hollander, Kaarlo Simojoki
1KYS, psykiatria ja farmakologia/toksikologia.
Duodecim; Laaketieteellinen Aikakauskirja
|November 12, 2011
Summary
Designer drugs, or novel psychoactive substances, pose a significant challenge to public health due to their unpredictable effects and rapid spread. Legal loopholes allow for continuous emergence of new substances, complicating control efforts.
Area of Science:
- Pharmacology
- Toxicology
- Public Health
Context:
- Designer drugs, marketed as legal alternatives, present emerging public health and substance abuse challenges.
- The rapid proliferation and unpredictable effects of these synthetic psychotropic substances strain healthcare systems.
- Existing regulatory frameworks struggle to keep pace with the continuous emergence of novel psychoactive substances.
Purpose:
- To highlight the challenges posed by designer drugs to healthcare and substance abuse care.
- To examine the regulatory difficulties in controlling the spread of designer drugs.
- To discuss the implications of legal classification processes on designer drug availability.
Summary:
- Designer drugs are synthetic psychoactive substances marketed as legal alternatives.
- Their rapid spread and unpredictable effects challenge health and substance abuse services.
- Regulatory lag, where new substances emerge faster than they can be classified as illegal, facilitates their distribution.
Impact:
- The study underscores the need for agile regulatory strategies to combat the evolving threat of designer drugs.
- It emphasizes the importance of adapting public health and substance abuse interventions to address novel psychoactive substances.
- The findings highlight the public health risks associated with the slow classification of illicit substances.
More Related Videos
Related Concept Videos
01:22CNS Stimulants: Psychedelic Agents
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
01:28An Overview of Psychoactive Drugs
Psychoactive drugs impact brain function, influencing perception, mood, consciousness, cognition, and behavior. These substances are grouped based on their effects and the mechanisms by which they act.
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:23Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
01:29Stimulants
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...